Literature DB >> 24419067

Age, race/ethnicity, and behavioral risk factors associated with per contact risk of HIV infection among men who have sex with men in the United States.

Hyman M Scott1, Eric Vittinghoff, Risha Irvin, Darpun Sachdev, Albert Liu, Marc Gurwith, Susan P Buchbinder.   

Abstract

OBJECTIVE: Young men who have sex with men (MSM) and MSM of color have the highest HIV incidence in the United States. To explore possible explanations for these disparities and known individual risk factors, we analyzed the per contact risk (PCR) of HIV seroconversion in the early highly active antiretroviral therapy era.
METHODS: Data from 3 longitudinal studies of MSM (HIV Network for Prevention Trials Vaccine Preparedness Study, EXPLORE behavioral efficacy trial, and VAX004 vaccine efficacy trial) were pooled. The analysis included visits where participants reported unprotected receptive anal intercourse (URA), protected receptive anal intercourse, or unprotected insertive anal intercourse (UIA) with an HIV seropositive, unknown HIV serostatus, or an HIV seronegative partner. We used regression standardization to estimate average PCRs for each type of contact, with bootstrap confidence intervals.
RESULTS: The estimated PCR was highest for URA with an HIV seropositive partner (0.73%; 95% bootstrap confidence interval [BCI]: 0.45% to 0.98%) followed by URA with a partner of unknown HIV serostatus (0.49%; 95% BCI: 0.32% to 0.62%). The estimated PCR for protected receptive anal intercourse and UIA with an HIV seropositive partner was 0.08% (95% BCI: 0.0% to 0.19%) and 0.22% (95% BCI: 0.05% to 0.39%), respectively. Average PCRs for URA and UIA with HIV seropositive partners were higher by 0.14%-0.34% among younger participants and higher by 0.08% for UIA among Latino participants compared with white participants. Estimated PCRs increased with the increasing number of sexual partners, use of methamphetamines or poppers, and history of sexually transmitted infection.
CONCLUSIONS: Susceptibility or partner factors may explain the higher HIV conversion risk for younger MSM, some MSM of color, and those reporting individual risk factors.

Entities:  

Mesh:

Year:  2014        PMID: 24419067      PMCID: PMC3894586          DOI: 10.1097/QAI.0b013e3182a98bae

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  25 in total

Review 1.  The role of sexually transmitted diseases in HIV transmission.

Authors:  Shannon R Galvin; Myron S Cohen
Journal:  Nat Rev Microbiol       Date:  2004-01       Impact factor: 60.633

Review 2.  Greater risk for HIV infection of black men who have sex with men: a critical literature review.

Authors:  Gregorio A Millett; John L Peterson; Richard J Wolitski; Ron Stall
Journal:  Am J Public Health       Date:  2006-05-02       Impact factor: 9.308

3.  Feasibility of human immunodeficiency virus vaccine trials in homosexual men in the United States: risk behavior, seroincidence, and willingness to participate.

Authors:  S P Buchbinder; J M Douglas; D J McKirnan; F N Judson; M H Katz; K M MacQueen
Journal:  J Infect Dis       Date:  1996-11       Impact factor: 5.226

4.  Per-contact risk of human immunodeficiency virus transmission between male sexual partners.

Authors:  E Vittinghoff; J Douglas; F Judson; D McKirnan; K MacQueen; S P Buchbinder
Journal:  Am J Epidemiol       Date:  1999-08-01       Impact factor: 4.897

5.  Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection.

Authors:  Neil M Flynn; Donald N Forthal; Clayton D Harro; Franklyn N Judson; Kenneth H Mayer; Michael F Para
Journal:  J Infect Dis       Date:  2005-01-27       Impact factor: 5.226

6.  Sexual risk, nitrite inhalant use, and lack of circumcision associated with HIV seroconversion in men who have sex with men in the United States.

Authors:  Susan P Buchbinder; Eric Vittinghoff; Patrick J Heagerty; Connie L Celum; George R Seage; Franklyn N Judson; David McKirnan; Kenneth H Mayer; Beryl A Koblin
Journal:  J Acquir Immune Defic Syndr       Date:  2005-05-01       Impact factor: 3.731

Review 7.  Social context, sexual networks, and racial disparities in rates of sexually transmitted infections.

Authors:  Adaora A Adimora; Victor J Schoenbach
Journal:  J Infect Dis       Date:  2005-02-01       Impact factor: 5.226

8.  Are US populations appropriate for trials of human immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness Study.

Authors:  G R Seage; S E Holte; D Metzger; B A Koblin; M Gross; C Celum; M Marmor; G Woody; K H Mayer; C Stevens; F N Judson; D McKirnan; A Sheon; S Self; S P Buchbinder
Journal:  Am J Epidemiol       Date:  2001-04-01       Impact factor: 4.897

Review 9.  Genital immunology and HIV susceptibility in young women.

Authors:  Tae Joon Yi; Brett Shannon; Jessica Prodger; Lyle McKinnon; Rupert Kaul
Journal:  Am J Reprod Immunol       Date:  2012-11-12       Impact factor: 3.886

10.  Effects of a behavioural intervention to reduce acquisition of HIV infection among men who have sex with men: the EXPLORE randomised controlled study.

Authors:  B Koblin; M Chesney; T Coates
Journal:  Lancet       Date:  2004 Jul 3-9       Impact factor: 79.321

View more
  37 in total

1.  A New Measure of the Perceived Influence of Sexually Explicit Online Media on the Sexual Behaviors of Men Who Have Sex With Men.

Authors:  Kimberly M Nelson; David W Pantalone; Kristi E Gamarel; Jane M Simoni
Journal:  J Sex Res       Date:  2015-10-19

2.  Use of poppers and HIV risk behaviours among men who have sex with men in Paris, France: an observational study.

Authors:  H Rhodes Hambrick; Su Hyun Park; Joseph J Palamar; Anthony Estreet; John A Schneider; Dustin T Duncan
Journal:  Sex Health       Date:  2018-07       Impact factor: 2.706

3.  Understanding the effects of different HIV transmission models in individual-based microsimulation of HIV epidemic dynamics in people who inject drugs.

Authors:  J F G Monteiro; D J Escudero; C Weinreb; T Flanigan; S Galea; S R Friedman; B D L Marshall
Journal:  Epidemiol Infect       Date:  2016-01-12       Impact factor: 2.451

4.  Preferences for Condomless Sex in Sexually Explicit Media Among Black/African American Men Who Have Sex with Men: Implications for HIV Prevention.

Authors:  Kimberly M Nelson; Lisa A Eaton; Kristi E Gamarel
Journal:  Arch Sex Behav       Date:  2016-12-16

5.  Methamphetamine augment HIV-1 Tat mediated memory deficits by altering the expression of synaptic proteins and neurotrophic factors.

Authors:  Anantha Ram Nookala; Daniel C Schwartz; Nitish S Chaudhari; Alexy Glazyrin; Edward B Stephens; Nancy E J Berman; Anil Kumar
Journal:  Brain Behav Immun       Date:  2018-05-02       Impact factor: 7.217

6.  Latent Classes of Sexual Risk Among Black Men Who Have Sex with Men and Women.

Authors:  Derek T Dangerfield; Nina T Harawa; Laramie R Smith; William L Jeffries; Lourdes Baezconde-Garbanati; Ricky Bluthenthal
Journal:  Arch Sex Behav       Date:  2018-03-14

7.  Screening for acute HIV infection in community-based settings: Cost-effectiveness and impact on transmissions.

Authors:  Martin Hoenigl; Antoine Chaillon; Sanjay R Mehta; Davey M Smith; Joshua Graff-Zivin; Susan J Little
Journal:  J Infect       Date:  2016-08-11       Impact factor: 6.072

Review 8.  Estimating per-act HIV transmission risk: a systematic review.

Authors:  Pragna Patel; Craig B Borkowf; John T Brooks; Arielle Lasry; Amy Lansky; Jonathan Mermin
Journal:  AIDS       Date:  2014-06-19       Impact factor: 4.177

9.  Age Cohort Differences in Sexual Behaviors Among Black Men Who Have Sex With Men and Women.

Authors:  Derek T Dangerfield; Nina T Harawa; M Isabel Fernandez; Sybil Hosek; Jennifer Lauby; Heather Joseph; Heather Guentzel Frank; Ricky N Bluthenthal
Journal:  J Sex Res       Date:  2018-01-29

10.  Incidence of HIV Infection and Sexually Transmitted Infections and Related Risk Factors Among Very Young Men Who Have Sex With Men.

Authors:  Robert Garofalo; Anna L Hotton; Lisa M Kuhns; Beau Gratzer; Brian Mustanski
Journal:  J Acquir Immune Defic Syndr       Date:  2016-05-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.